Device Infant

Fisher & Paykel Healthcare

Payments companies reported to CMS as associated with Fisher & Paykel Healthcare. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4.0Massociated payments (2023-2025)
8,549clinicians with associated payments
2companies reporting

By year

2023 $1.2M
2024 $1.1M
2025 $1.7M

Payments reported as associated with Fisher & Paykel Healthcare, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Nurse Anesthetist, Certified Registered $1.1M
Anesthesiology $977K
Pulmonary Disease $361K
Emergency Medicine $293K
Pediatric Critical Care Medicine $172K
Pediatrics $167K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Fisher & Paykel Healthcare

These are the largest totals companies reported as associated with Fisher & Paykel Healthcare. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Durick Oakland, CA Anesthesiology $149,287.55
Anna Suessman Dallas, TX Pediatrics $127,306.20
Alberto Marante Orlando, FL Pediatric Critical Care Medicine $119,365.05
Joseph Ojile Saint Louis, MO Pulmonary Disease $113,579.64
Elizabeth Behringer Orange, CA Anesthesiology $102,482.75
David Rapoport New York, NY Sleep Medicine (Internal Medicine) $76,904.43
Eddy Gutierrez Jacksonville, FL Critical Care Medicine (Internal Medicine) $69,581.70
Douglas Massey San Antonio, TX Nurse Anesthetist, Certified Registered $53,327.35
James Neuenschwander Mount Vernon, OH Emergency Medicine $52,740.17
David Hutchinson Gainesville, FL Anesthesiology $49,487.15

Prescribed Fisher & Paykel Healthcare?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.